{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:59:35Z","timestamp":1794484775772,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.autrev.2024.103648","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:38:05Z","timestamp":1727458685000},"page":"103648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Immunopathogenesis of systemic lupus erythematosus: An update"],"prefix":"10.1016","volume":"23","author":[{"given":"Laurent","family":"Arnaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103648_bb0005","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/1744666X.2023.2240959","article-title":"A review of genetic risk in systemic lupus erythematosus","volume":"19","author":"Guga","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103648_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152143","article-title":"Risk prediction models for incident systemic lupus erythematosus among women in the Nurses\u2019 health study cohorts using genetics, family history, and lifestyle and environmental factors","volume":"58","author":"Cui","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103648_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105627","article-title":"Type 1 interferons: a target for immune-mediated inflammatory diseases (IMIDs)","volume":"91","author":"Mathian","year":"2024","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2024.103648_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101865","article-title":"New and future therapies: changes in the therapeutic armamentarium for SLE","volume":"37","author":"Askanase","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/annrheumdis-2020-219373","article-title":"European league against rheumatism (EULAR)\/American College of Rheumatology (ACR) SLE classification criteria item performance","volume":"80","author":"Aringer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103648_bb0035","first-page":"kead548","article-title":"Prevalence, characteristics, and knowledge related to photosensitivity in patients with lupus erythematosus: the international PHOTOLUP study","author":"Battesti","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103648_bb0040","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103648_bb0045","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/art.42460","article-title":"Regulation of photosensitivity by the hippo pathway in lupus skin","volume":"75","author":"Hile","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0050","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0961203320916517","article-title":"Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity","volume":"29","author":"Hirahara","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103648_bb0055","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/art.41799","article-title":"Lupus susceptibility region containing CDKN1B rs34330 mechanistically influences expression and function of multiple target genes, also linked to proliferation and apoptosis","volume":"73","author":"Singh","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000752","article-title":"Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease","volume":"9","author":"Yavuz","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0065","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3389\/fimmu.2017.01216","article-title":"CD95\/Fas, non-apoptotic signaling pathways, and kinases","volume":"8","author":"Le Gallo","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13010","article-title":"Microparticles as autoantigens in systemic lupus erythematosus","volume":"48","author":"Mobarrez","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2024.103648_bb0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/1744666X.2018.1474100","article-title":"Microparticles - culprits in the pathogenesis of systemic lupus erythematosus?","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fimmu.2018.00322","article-title":"Potential involvement of platelet-derived microparticles and microparticles forming immune complexes during monocyte activation in patients with systemic lupus erythematosus","volume":"9","author":"Burbano","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0085","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","article-title":"Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus","volume":"77","author":"Kato","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103648_bb0090","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.39417","article-title":"Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis","volume":"68","author":"Dieker","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0095","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3389\/fimmu.2017.01136","article-title":"Acetylated histones in apoptotic microparticles drive the formation of neutrophil extracellular traps in active lupus nephritis","volume":"8","author":"Rother","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103073","article-title":"Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP","volume":"139","author":"Karlsson","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103648_bb0105","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.3390\/ijms24119210","article-title":"Markers of NETosis in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"24","author":"Reshetnyak","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103648_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0115","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0120","article-title":"Decreased miR-4512 levels in monocytes and macrophages of individuals with systemic lupus erythematosus contribute to innate immune activation and Neutrsophil NETosis by targeting TLR4 and CXCL2","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0125","first-page":"644","article-title":"Nicotine drives neutrophil extracellular traps formation and accelerates collagen-induced arthritis","volume":"56","author":"Lee","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103648_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102393","article-title":"Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"18","author":"Parisis","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103648_bb0135","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/jcm10040856","article-title":"Implications of endogenous Retroelements in the Etiopathogenesis of systemic lupus erythematosus","volume":"10","author":"Ukadike","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2017.10.004","article-title":"Defective regulation of L1 endogenous retroelements in primary Sjogren\u2019s syndrome and systemic lupus erythematosus: role of methylating enzymes","volume":"88","author":"Mavragani","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103648_bb0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/jhg.2013.140","article-title":"Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls","volume":"59","author":"Sukapan","year":"2014","journal-title":"J Hum Genet"},{"key":"10.1016\/j.autrev.2024.103648_bb0150","first-page":"1636","article-title":"Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity","volume":"40","author":"Antiochos","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0155","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1055\/a-1825-2915","article-title":"Enrichment of complement, immunoglobulins, and autoantibody targets in the proteome of platelets from patients with systemic lupus erythematosus","volume":"122","author":"Linge","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2024.103648_bb0160","doi-asserted-by":"crossref","first-page":"eaav5928","DOI":"10.1126\/scitranslmed.aav5928","article-title":"Platelets release mitochondrial antigens in systemic lupus erythematosus","volume":"13","author":"Melki","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.42382","article-title":"Platelet LGALS3BP as a mediator of myeloid inflammation in systemic lupus erythematosus","volume":"75","author":"El Bannoudi","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi4994","article-title":"Erratum for the Research Article: \u201cSelectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis\u201d","volume":"13","author":"Scherlinger","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/kead296","article-title":"Platelet TLR7 is essential for the formation of platelet-neutrophil complexes and low-density neutrophils in lupus nephritis","volume":"63","author":"Tay","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103648_bb0180","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.cmet.2021.08.008","article-title":"Erythrocyte-derived mitochondria take to the lupus stage","volume":"33","author":"Lepelley","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2024.103648_bb0185","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103648_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-immunol-051116-052331","article-title":"Intracellular nucleic acid detection in autoimmunity","volume":"35","author":"Crowl","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0195","doi-asserted-by":"crossref","first-page":"2553901","DOI":"10.1155\/2022\/2553901","article-title":"Copy number variation and frequency of rs179008 in TLR7 gene associated with systemic lupus erythematosus in two Mexican populations","volume":"2022","author":"Pacheco","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2024.103648_bb0200","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3389\/fimmu.2019.03054","article-title":"TLR7 Agonism accelerates disease and causes a fatal myeloproliferative disorder in NZM 2410 lupus mice","volume":"10","author":"Wirth","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0205","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2018.01957","article-title":"Up-regulation of TLR7-mediated IFN-\u03b1 production by Plasmacytoid dendritic cells in patients with systemic lupus erythematosus","volume":"9","author":"Sakata","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0210","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13075-017-1441-7","article-title":"Enhanced IFN-\u03b1 production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus","volume":"19","author":"Murayama","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103648_bb0215","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI132328","article-title":"B cell-intrinsic TLR9 expression is protective in murine lupus","volume":"130","author":"Tilstra","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2024.103648_bb0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4049\/jimmunol.1501943","article-title":"TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in Pristane-induced murine lupus","volume":"197","author":"Bossaller","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0225","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96795","article-title":"Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus","volume":"3","author":"Gies","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2024.103648_bb0230","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13075-014-0477-1","article-title":"Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation","volume":"16","author":"Sieber","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103648_bb0235","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41590-022-01310-2","article-title":"Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus","volume":"23","author":"Leibler","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0240","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172219","article-title":"B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice","volume":"8","author":"Cosgrove","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2024.103648_bb0245","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature09102","article-title":"TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus","volume":"465","author":"Guiducci","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103648_bb0250","doi-asserted-by":"crossref","first-page":"eabn2263","DOI":"10.1126\/scitranslmed.abn2263","article-title":"Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation","volume":"14","author":"Billi","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0255","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/rheumatology\/keaa167","article-title":"Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers","volume":"59","author":"Chasset","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103648_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001032","article-title":"Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE prospective observational cohort study (SPOCS) by interferon gene signature","volume":"10","author":"Arnaud","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0265","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0270","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2024.103648_bb0275","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0280","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/jcm8081244","article-title":"Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes","volume":"8","author":"Berthier","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0285","doi-asserted-by":"crossref","first-page":"eaax1159","DOI":"10.1126\/scitranslmed.aax1159","article-title":"PD-1H (VISTA)\u2013mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus","volume":"11","author":"Han","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0290","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1600-0560.2010.01587.x","article-title":"Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner\u2019s lymphocytic infiltrate of the skin and cutaneous lupus erythematosus","volume":"37","author":"Tomasini","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.autrev.2024.103648_bb0295","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.imbio.2009.06.013","article-title":"Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage","volume":"214","author":"Vermi","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2024.103648_bb0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1191\/096120301678416042","article-title":"Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus","volume":"10","author":"Blomberg","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103648_bb0305","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42235","article-title":"Multidimensional immune profiling of cutaneous lupus erythematosus in vivo stratified by patient response to Antimalarials","volume":"74","author":"Patel","year":"2022","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103648_bb0310","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jid.2023.10.039","article-title":"Plasmacytoid dendritic cells are not major producers of type 1 IFN in cutaneous lupus: an in-depth Immunoprofile of subacute and discoid lupus","volume":"144","author":"Vazquez","year":"2024","journal-title":"J Investigat Dermatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jid.2016.09.008","article-title":"Lupus skin is primed for IL-6 inflammatory responses through a keratinocyte-mediated autocrine type I interferon loop","volume":"137","author":"Stannard","year":"2017","journal-title":"J Investigat Dermatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0320","doi-asserted-by":"crossref","first-page":"1359714","DOI":"10.3389\/flupu.2024.1359714","article-title":"A critical role for IFN-\u03b2 signaling for IFN-\u03ba induction in keratinocytes","volume":"2","author":"Xu","year":"2024","journal-title":"Front Lupus"},{"key":"10.1016\/j.autrev.2024.103648_bb0325","doi-asserted-by":"crossref","first-page":"39765","DOI":"10.1074\/jbc.M102502200","article-title":"Interferon-\u03ba, a novel type I interferon expressed in human keratinocytes","volume":"276","author":"LaFleur","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2024.103648_bb0330","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.2100548","article-title":"Cutting edge: a threshold of B cell costimulatory signals is required for spontaneous germinal center formation in autoimmunity","volume":"207","author":"Chiang","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0335","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4049\/jimmunol.1901358","article-title":"TNF-\u03b1 regulates human Plasmacytoid dendritic cells by suppressing IFN-\u03b1 production and enhancing T cell activation","volume":"206","author":"Psarras","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0340","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1056\/NEJMoa2118025","article-title":"Trial of anti-BDCA2 antibody Litifilimab for systemic lupus erythematosus","volume":"387","author":"Furie","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0345","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa2118024","article-title":"Trial of anti-BDCA2 antibody Litifilimab for cutaneous lupus erythematosus","volume":"387","author":"Werth","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0350","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2024.103648_bb0355","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jid.2017.03.016","article-title":"IL-21 may promote granzyme B-dependent NK\/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus","volume":"137","author":"Salvi","year":"2017","journal-title":"J Investigat Dermatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0360","series-title":"AB0115 CD14+ myeloid cells express the PDC markers BDCA-2, BDCA-4, CD123 upon differentiation in both healthy individuals and SLE patients","author":"Psarras","year":"2023"},{"key":"10.1016\/j.autrev.2024.103648_bb0365","doi-asserted-by":"crossref","first-page":"eabf8442","DOI":"10.1126\/scitranslmed.abf8442","article-title":"Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus","volume":"13","author":"Karnell","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2024.103648_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2019.06.009","article-title":"The contribution of macrophages to systemic lupus erythematosus","volume":"207","author":"Ma","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734008","article-title":"Macrophage polarization and plasticity in systemic lupus erythematosus","volume":"12","author":"Ahamada","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0385","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159751","article-title":"Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis","volume":"7","author":"Richoz","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2024.103648_bb0390","article-title":"Diverse roles of NETosis in the pathogenesis of lupus","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0395","doi-asserted-by":"crossref","first-page":"1320444","DOI":"10.3389\/fimmu.2024.1320444","article-title":"Enhanced GATA4 expression in senescent systemic lupus erythematosus monocytes promotes high levels of IFN\u03b1 production","volume":"15","author":"Kuga","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0400","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.cell.2016.05.057","article-title":"Personalized Immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2024.103648_bb0405","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.4049\/jimmunol.1700588","article-title":"Downregulation of CD3\u03b6 in NK cells from systemic lupus erythematosus patients confers a Proinflammatory phenotype","volume":"200","author":"Su\u00e1rez-Fueyo","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0415","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.42270","article-title":"Strong Association of Combined Genetic Deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome","volume":"74","author":"Lundtoft","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0420","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958392","article-title":"Anaphylatoxins spark the flame in early autoimmunity","volume":"13","author":"Schanzenbacher","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0430","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","article-title":"Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice","volume":"119","author":"Kil","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2024.103648_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105523","article-title":"New biologics and targeted therapies in systemic lupus: from new molecular targets to new indications. A systematic review","volume":"90","author":"Felten","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2024.103648_bb0440","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41584-021-00574-6","article-title":"Reply to: diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis","volume":"17","author":"Pisetsky","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103648_bb0445","doi-asserted-by":"crossref","first-page":"1093208","DOI":"10.3389\/fimmu.2023.1093208","article-title":"Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus","volume":"14","author":"Wen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0450","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri.2017.24","article-title":"Altered B cell signalling in autoimmunity","volume":"17","author":"Rawlings","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0455","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbspin.2012.04.010","article-title":"Regulatory B cells play a key role in immune system balance","volume":"80","author":"Berthelot","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2024.103648_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","article-title":"Effector and regulatory B cells in immune-mediated kidney disease","volume":"15","author":"Oleinika","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.autrev.2024.103648_bb0465","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","article-title":"Global natural regulatory T cell depletion in active systemic lupus erythematosus","volume":"175","author":"Miyara","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0470","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179433","article-title":"Selective CAR T cell-mediated B cell depletion suppresses IFN signature in SLE","volume":"9","author":"Wilhelm","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2024.103648_bb0475","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/1744666X.2019.1593141","article-title":"The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target","volume":"15","author":"Koga","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0480","series-title":"Interleukin-17 and Lupus: Enough to be a Target? For Which Patients? - PubMed","year":"2024"},{"key":"10.1016\/j.autrev.2024.103648_bb0485","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/ard-2023-224225","article-title":"T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases","volume":"82","author":"Akiyama","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103648_bb0490","series-title":"Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus - PubMed","year":"2024"},{"key":"10.1016\/j.autrev.2024.103648_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350915","article-title":"Blockade of OX40\/OX40L signaling using anti-OX40L alleviates murine lupus nephritis","author":"Zhao","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0500","series-title":"PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus - PubMed","year":"2024"},{"key":"10.1016\/j.autrev.2024.103648_bb0505","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cei.13288","article-title":"The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases","volume":"197","author":"Mohr","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0510","series-title":"Interferon-\u03b1 activates interleukin-1 receptor-associated kinase 1 to induce regulatory T-cell apoptosis in patients with systemic lupus erythematosus - PubMed","year":"2024"},{"key":"10.1016\/j.autrev.2024.103648_bb0515","doi-asserted-by":"crossref","first-page":"ii19","DOI":"10.1093\/ndt\/gfad186","article-title":"The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases","volume":"38","author":"Odler","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2024.103648_bb0520","doi-asserted-by":"crossref","first-page":"1257085","DOI":"10.3389\/fimmu.2023.1257085","article-title":"Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus","volume":"14","author":"Lindblom","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103648_bb0525","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cei.13371","article-title":"Dysregulated Fc\u03b3 receptor IIa-induced cytokine production in dendritic cells of lupus nephritis patients","volume":"199","author":"Newling","year":"2020","journal-title":"Clin Exp Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:00:08Z","timestamp":1728478808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1568997224001393"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103648","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopathogenesis of systemic lupus erythematosus: An update","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103648"}}